aTyr Pharma Inc
Change company Symbol lookup
Select an option...
LIFE aTyr Pharma Inc
ITT ITT Inc
PLBY Plby Group Inc
SVFA SVF Investment Corp
ROIUF Route1 Inc
MPB Mid Penn Bancorp Inc
NWSA News Corp
BAC Bank of America Corp
BA Boeing Co
EGRNF China Evergrande Group
Go

Health Care : Biotechnology | Small Cap Value
Company profile

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.

Closing Price
$10.31
Day's Change
0.05 (0.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.54
Day's Low
9.31
Volume
(Light)
Volume:
8,669,072

10-day average volume:
27,308,933
8,669,072

Company Profile

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
78.87x
Price/Book (MRQ)
4.08x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

August 2021
Current Month
414.7K
Previous Month
546.5K
Percent of Float
2.55%
Days to Cover
3.0033 Days

Share Information

LIFE is in a share class of common stock
Float
16.3M
Shares Outstanding
16.9M
Institutions Holding Shares
30
49.20%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • John K. Clarke
  • Sanjay S. ShuklaPres.
  • Jill M. BroadfootCFO
  • Nancy E. DenyesCounsel
  • Sara ZaknoenDir.

Address

Insider Trading

During the most recent quarter, 60K shares were bought, and 3K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.